Global Travel Media » Blog Archive Genoox Names Andy Page to lead its Advisory Board | Global Travel Media

Home » Movers & Shakers » Currently Reading:

[sam id="86" codes="true"]

Genoox Names Andy Page to lead its Advisory Board

January 25, 2022 Movers & Shakers No Comments

Genoox,  the community-driven genomic data platform, today announced that Andy Page has joined to lead its Advisory Board, adding the healthtech veteran’s extensive knowledge and understanding of the industry to the company.

Genoox’s platform connects clinicians, genetic counselors and healthcare organizations enabling them to collaborate on challenging questions, confirm patient treatment options and contribute to various research initiatives.  The database is supported by AI and ML tools and applications, providing a comprehensive analysis of genomic data.  As former CEO of Caption Health and former President of 23andMe, Livongo and Everly Health, Page’s knowledge and experience in the healthcare industry  provides a wealth of knowledge that will help the company scale up quickly.

“Genoox’s innovative AI driven platform is disrupting the way the healthcare industry is using genomic insights,” said Page. “By making curated real-world data instantly accessible, we assist our growing professional community by accelerating time to answers, providing actionable genetic information and establishing care pathways that support patients at the point of care.”

“Andy has tremendous experience with rapidly growing, consumer driven healthcare,” says Ohad Arazi, Chairman of the Board for Genoox. “His leadership position on our advisory board will help guide our growth strategy of leveraging accurate and actionable genomic insights that guide clinical decisions and enable more targeted therapy.”

“We are honored that Andy Page is joining our team, as we materially accelerate our growth,” said Amir Trabelsi, CEO and co-founder of Genoox. “Our community of genetic users has grown four times over the past year with more than 25,000 experts analyzing more than 6,000 genetic cases a month. With Andy’s extensive experience in growing companies and reputation in the industry we are poised to further scale up our company in 2022 and beyond.”

0 0 votes
Article Rating

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Comment on this Article:







Subscribe To Receive Our Daily Global Travel Media Newsletter

The FIRST Australian-based news alert is to be delivered every Morning to your Inbox before you arrive at your desk.

Sponsor / Partners

Luxury Traveller by Robert La Bua – SideBar  Position -1
Top 25 Restaurants

 

ADVERTISEMENTS

CT Partners Tower

ADVERTISEMENTS

ADVERTISEMENTS

ADVERTISEMENTS

ADVERTISEMENTS

TravelManagers Tower Banner Nov

GLOBAL TRAVEL MEDIA VIDEOS

 

 

 

CT Partners Tower

Advertisments

TravelManagers NOV Leader / Footer Banner
0
Would love your thoughts, please comment.x
()
x
%d bloggers like this:
0
Would love your thoughts, please comment.x
()
x
%d bloggers like this:
sitemap